Connection

Marco Metra to Male

This is a "connection" page, showing publications Marco Metra has written about Male.
Connection Strength

0.502
  1. Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study. Europace. 2021 10 09; 23(10):1603-1611.
    View in: PubMed
    Score: 0.013
  2. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study. Eur J Heart Fail. 2020 12; 22(12):2238-2247.
    View in: PubMed
    Score: 0.012
  3. Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study. Clin Res Cardiol. 2021 Jul; 110(7):1020-1028.
    View in: PubMed
    Score: 0.012
  4. Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown). 2020 Nov; 21(11):874-881.
    View in: PubMed
    Score: 0.012
  5. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020 05 14; 41(19):1821-1829.
    View in: PubMed
    Score: 0.012
  6. Effects of Serelaxin in Patients with Acute Heart Failure. N Engl J Med. 2019 08 22; 381(8):716-726.
    View in: PubMed
    Score: 0.011
  7. Focus on echocardiographic right ventricular strain analysis in cystic fibrosis adults without cardiovascular risk factors: a case-control study. Intern Emerg Med. 2019 11; 14(8):1279-1285.
    View in: PubMed
    Score: 0.011
  8. Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. J Rheumatol. 2019 06; 46(6):603-608.
    View in: PubMed
    Score: 0.011
  9. The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction. Clin Exp Rheumatol. 2018 Jul-Aug; 36 Suppl 113(4):135-141.
    View in: PubMed
    Score: 0.011
  10. Prognostic evaluation of the elastic properties of the ascending aorta in dilated cardiomyopathy. Eur J Clin Invest. 2018 Jul; 48(7):e12950.
    View in: PubMed
    Score: 0.010
  11. Prognostic Significance of Creatinine Increases During an Acute Heart Failure Admission in Patients With and Without Residual Congestion: A Post Hoc Analysis of the PROTECT Data. Circ Heart Fail. 2018 05; 11(5):e004644.
    View in: PubMed
    Score: 0.010
  12. N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor. Front Immunol. 2018; 9:574.
    View in: PubMed
    Score: 0.010
  13. Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients. Cardiovasc Ther. 2018 Jun; 36(3):e12323.
    View in: PubMed
    Score: 0.010
  14. The role of type 2 diabetes mellitus on hypertensive-related aortic stiffness. Echocardiography. 2018 06; 35(6):798-803.
    View in: PubMed
    Score: 0.010
  15. Site enrollment rate, outcomes, and study drug effects in a multicenter trial. Results from RELAX-AHF. Int J Cardiol. 2018 02 15; 253:91-96.
    View in: PubMed
    Score: 0.010
  16. Angiotensin II type 2 receptor (AT2R) as a novel modulator of inflammation in rheumatoid arthritis synovium. Sci Rep. 2017 10 16; 7(1):13293.
    View in: PubMed
    Score: 0.010
  17. Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis. PLoS One. 2017; 12(8):e0183102.
    View in: PubMed
    Score: 0.010
  18. Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis. J Rheumatol. 2017 08; 44(8):1190-1197.
    View in: PubMed
    Score: 0.010
  19. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study. Eur J Heart Fail. 2017 06; 19(6):800-809.
    View in: PubMed
    Score: 0.010
  20. Heart failure. Lancet. 2017 Oct 28; 390(10106):1981-1995.
    View in: PubMed
    Score: 0.010
  21. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls". Semin Arthritis Rheum. 2017 08; 47(1):79-85.
    View in: PubMed
    Score: 0.010
  22. Day vs night: Does time of presentation matter in acute heart failure? A secondary analysis from the RELAX-AHF trial. Am Heart J. 2017 May; 187:62-69.
    View in: PubMed
    Score: 0.010
  23. Proangiogenic effects of soluble a-Klotho on systemic sclerosis dermal microvascular endothelial cells. Arthritis Res Ther. 2017 Feb 10; 19(1):27.
    View in: PubMed
    Score: 0.010
  24. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Ann Rheum Dis. 2017 May; 76(5):924-934.
    View in: PubMed
    Score: 0.009
  25. Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis. Arthritis Res Ther. 2015 Aug 21; 17:221.
    View in: PubMed
    Score: 0.009
  26. Acute heart failure in elderly patients: worse outcomes and differential utility of standard prognostic variables. Insights from the PROTECT trial. Eur J Heart Fail. 2015 Jan; 17(1):109-18.
    View in: PubMed
    Score: 0.008
  27. SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study. Clin Res Cardiol. 2021 Nov; 110(11):1822-1831.
    View in: PubMed
    Score: 0.003
  28. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020 12 12; 396(10266):1895-1904.
    View in: PubMed
    Score: 0.003
  29. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. JAMA Cardiol. 2020 Nov 01; 5(11):1274-1280.
    View in: PubMed
    Score: 0.003
  30. Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience. Eur J Cardiothorac Surg. 2020 11 01; 58(5):899-906.
    View in: PubMed
    Score: 0.003
  31. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak. JACC Heart Fail. 2021 01; 9(1):52-61.
    View in: PubMed
    Score: 0.003
  32. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. Eur Heart J. 2020 05 14; 41(19):1810-1817.
    View in: PubMed
    Score: 0.003
  33. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul; 19(7):102568.
    View in: PubMed
    Score: 0.003
  34. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation. 2020 06 23; 141(25):2113-2116.
    View in: PubMed
    Score: 0.003
  35. Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. JACC Heart Fail. 2019 11; 7(11):970-979.
    View in: PubMed
    Score: 0.003
  36. Trajectories of Changes in Renal Function in Patients with Acute Heart Failure. J Card Fail. 2019 Nov; 25(11):866-874.
    View in: PubMed
    Score: 0.003
  37. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study. Eur J Heart Fail. 2019 08; 21(8):965-973.
    View in: PubMed
    Score: 0.003
  38. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019 May; 21(5):553-576.
    View in: PubMed
    Score: 0.003
  39. Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study. Clin Exp Med. 2019 Aug; 19(3):357-366.
    View in: PubMed
    Score: 0.003
  40. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction. Heart. 2019 08; 105(15):1182-1189.
    View in: PubMed
    Score: 0.003
  41. Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure. Eur J Heart Fail. 2019 06; 21(6):732-743.
    View in: PubMed
    Score: 0.003
  42. EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis. J Cardiovasc Med (Hagerstown). 2019 Mar; 20(3):131-136.
    View in: PubMed
    Score: 0.003
  43. Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure. Eur J Heart Fail. 2019 05; 21(5):624-633.
    View in: PubMed
    Score: 0.003
  44. Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years. Eur J Heart Fail. 2019 02; 21(2):208-217.
    View in: PubMed
    Score: 0.003
  45. Clinical correlates and outcome associated with changes in 6-minute walking distance in patients with heart failure: findings from the BIOSTAT-CHF study. Eur J Heart Fail. 2019 02; 21(2):218-226.
    View in: PubMed
    Score: 0.003
  46. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry. Eur J Heart Fail. 2019 02; 21(2):196-204.
    View in: PubMed
    Score: 0.003
  47. Impact of EUSTAR standardized training on accuracy of modified Rodnan skin score in patients with systemic sclerosis. Int J Rheum Dis. 2019 Jan; 22(1):96-102.
    View in: PubMed
    Score: 0.003
  48. Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation. Cardiovasc Pathol. 2019 Jan - Feb; 38:21-24.
    View in: PubMed
    Score: 0.003
  49. Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points. Circ Cardiovasc Qual Outcomes. 2018 10; 11(10):e004783.
    View in: PubMed
    Score: 0.003
  50. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. 2018 Jul-Aug; 36 Suppl 113(4):68-75.
    View in: PubMed
    Score: 0.003
  51. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study. Arthritis Rheumatol. 2018 11; 70(11):1829-1834.
    View in: PubMed
    Score: 0.003
  52. Irreversible proteasome inhibition with carfilzomib as first line therapy in patients with newly diagnosed multiple myeloma: Early in vivo cardiovascular effects. Eur J Pharmacol. 2018 Nov 05; 838:85-90.
    View in: PubMed
    Score: 0.003
  53. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction. J Am Coll Cardiol. 2018 09 04; 72(10):1081-1090.
    View in: PubMed
    Score: 0.003
  54. Echocardiographic evaluation of diastolic dysfunction in young and healthy patients with psoriasis: A case-control study. Monaldi Arch Chest Dis. 2018 09 04; 88(3):934.
    View in: PubMed
    Score: 0.003
  55. Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2018 09; 70(9):1373-1384.
    View in: PubMed
    Score: 0.003
  56. Near-infrared spectroscopic imaging of the whole hand: A new tool to assess tissue perfusion and peripheral microcirculation in scleroderma. Semin Arthritis Rheum. 2019 04; 48(5):867-873.
    View in: PubMed
    Score: 0.003
  57. Dose-dependent efficacy of ß-blocker in patients with chronic heart failure and atrial fibrillation. Int J Cardiol. 2018 Dec 15; 273:141-146.
    View in: PubMed
    Score: 0.003
  58. Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial. J Card Fail. 2018 Aug; 24(8):512-519.
    View in: PubMed
    Score: 0.003
  59. Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis. Ann Rheum Dis. 2018 11; 77(11):1665-1674.
    View in: PubMed
    Score: 0.003
  60. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. Int J Cardiol. 2018 11 15; 271:132-139.
    View in: PubMed
    Score: 0.003
  61. Waist-to-hip ratio and mortality in heart failure. Eur J Heart Fail. 2018 09; 20(9):1269-1277.
    View in: PubMed
    Score: 0.003
  62. Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2018 05 01; 57(5):813-817.
    View in: PubMed
    Score: 0.003
  63. Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure. Int J Cardiol. 2018 05 01; 258:185-191.
    View in: PubMed
    Score: 0.003
  64. Kounis syndrome, a disease to know: Case report and review of the literature. Monaldi Arch Chest Dis. 2018 03 16; 88(1):898.
    View in: PubMed
    Score: 0.003
  65. Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. JACC Heart Fail. 2018 04; 6(4):298-307.
    View in: PubMed
    Score: 0.003
  66. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. Int J Cardiol. 2018 02 15; 253:84-90.
    View in: PubMed
    Score: 0.003
  67. Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology (Oxford). 2018 02 01; 57(2):370-381.
    View in: PubMed
    Score: 0.003
  68. Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group. Arthritis Res Ther. 2018 01 30; 20(1):17.
    View in: PubMed
    Score: 0.003
  69. Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF. J Am Coll Cardiol. 2018 01 30; 71(4):386-398.
    View in: PubMed
    Score: 0.003
  70. Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis. Arthritis Rheumatol. 2018 02; 70(2):162-170.
    View in: PubMed
    Score: 0.003
  71. Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF. Eur J Heart Fail. 2018 05; 20(5):923-930.
    View in: PubMed
    Score: 0.003
  72. Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Ann Rheum Dis. 2018 04; 77(4):563-570.
    View in: PubMed
    Score: 0.003
  73. Proportional pulse pressure relates to cardiac index in stabilized acute heart failure patients. Clin Exp Hypertens. 2018; 40(7):637-643.
    View in: PubMed
    Score: 0.003
  74. Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failure. Eur J Heart Fail. 2018 02; 20(2):260-267.
    View in: PubMed
    Score: 0.003
  75. High-dose atorvastatin versus moderate dose on early vascular protection after ST-elevation myocardial infarction. Drug Des Devel Ther. 2017; 11:3425-3434.
    View in: PubMed
    Score: 0.003
  76. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2018 02; 20(2):304-314.
    View in: PubMed
    Score: 0.002
  77. The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis. J Am Coll Cardiol. 2017 Oct 24; 70(17):2128-2136.
    View in: PubMed
    Score: 0.002
  78. Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: early and midterm outcomes. EuroIntervention. 2017 Oct 13; 13(9):e1032-e1039.
    View in: PubMed
    Score: 0.002
  79. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality. Circulation. 2018 03 27; 137(13):1320-1330.
    View in: PubMed
    Score: 0.002
  80. Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF. Clin Res Cardiol. 2018 Feb; 107(2):170-181.
    View in: PubMed
    Score: 0.002
  81. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail. 2018 04; 20(4):700-710.
    View in: PubMed
    Score: 0.002
  82. Long-term treatment of scleroderma-related digital ulcers with iloprost: a cohort study. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):179-183.
    View in: PubMed
    Score: 0.002
  83. Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe? Eur J Heart Fail. 2018 02; 20(2):317-322.
    View in: PubMed
    Score: 0.002
  84. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017 11; 76(11):1897-1905.
    View in: PubMed
    Score: 0.002
  85. Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart. 2018 04; 104(7):606-613.
    View in: PubMed
    Score: 0.002
  86. Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF). Eur Heart J. 2017 Aug 07; 38(30):2364-2373.
    View in: PubMed
    Score: 0.002
  87. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency. Circulation. 2017 Oct 10; 136(15):1374-1383.
    View in: PubMed
    Score: 0.002
  88. Plasma Neutrophil Gelatinase-Associated Lipocalin and Predicting Clinically Relevant Worsening Renal Function in Acute Heart Failure. Int J Mol Sci. 2017 07 08; 18(7).
    View in: PubMed
    Score: 0.002
  89. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. J Am Coll Cardiol. 2017 Jun 27; 69(25):3029-3039.
    View in: PubMed
    Score: 0.002
  90. Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):114-121.
    View in: PubMed
    Score: 0.002
  91. Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction. JACC Heart Fail. 2017 07; 5(7):507-517.
    View in: PubMed
    Score: 0.002
  92. Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure. Cardiovasc Drugs Ther. 2017 Jun; 31(3):281-293.
    View in: PubMed
    Score: 0.002
  93. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study. Eur J Heart Fail. 2017 11; 19(11):1520-1529.
    View in: PubMed
    Score: 0.002
  94. Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial. Am Heart J. 2017 Aug; 190:113-122.
    View in: PubMed
    Score: 0.002
  95. Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis. Ann Rheum Dis. 2018 04; 77(4):626-628.
    View in: PubMed
    Score: 0.002
  96. The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease: a multicentre European Scleroderma Trials and Research group (EUSTAR) study. Rheumatology (Oxford). 2017 05 01; 56(5):844-852.
    View in: PubMed
    Score: 0.002
  97. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial. Eur J Heart Fail. 2017 11; 19(11):1495-1503.
    View in: PubMed
    Score: 0.002
  98. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). Eur J Heart Fail. 2017 06; 19(6):739-747.
    View in: PubMed
    Score: 0.002
  99. Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. Eur Heart J. 2017 Mar 01; 38(9):648-660.
    View in: PubMed
    Score: 0.002
  100. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure. Eur J Heart Fail. 2017 05; 19(5):627-634.
    View in: PubMed
    Score: 0.002
  101. Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure. Eur J Heart Fail. 2017 06; 19(6):728-738.
    View in: PubMed
    Score: 0.002
  102. Autoimmune Tautology in a Complex Case of Polyautoimmunity: Systemic Sclerosis, Autoimmune Liver Involvement, Antiphospholipid Syndrome and Hashimoto's Thyroiditis. Isr Med Assoc J. 2017 Mar; 19(3):193-195.
    View in: PubMed
    Score: 0.002
  103. Prognostic role of ß-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail. 2017 07; 19(7):904-914.
    View in: PubMed
    Score: 0.002
  104. Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience. Int J Cardiol. 2017 May 01; 234:53-57.
    View in: PubMed
    Score: 0.002
  105. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Ann Rheum Dis. 2017 Jul; 76(7):1207-1218.
    View in: PubMed
    Score: 0.002
  106. Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol. 2017 Jun; 106(6):444-456.
    View in: PubMed
    Score: 0.002
  107. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Eur J Heart Fail. 2017 08; 19(8):1001-1010.
    View in: PubMed
    Score: 0.002
  108. Clinical response to golimumab in rheumatoid arthritis patients who were receiving etanercept or adalimumab: results of a multicenter active treatment study. Curr Med Res Opin. 2017 04; 33(4):657-666.
    View in: PubMed
    Score: 0.002
  109. Associations of Body Mass Index With Laboratory and Biomarkers in Patients With Acute Heart Failure. Circ Heart Fail. 2017 Jan; 10(1).
    View in: PubMed
    Score: 0.002
  110. Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension. PLoS One. 2016; 11(12):e0168706.
    View in: PubMed
    Score: 0.002
  111. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48. Eur J Heart Fail. 2016 09; 18(9):1153-61.
    View in: PubMed
    Score: 0.002
  112. The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis. J Rheumatol. 2016 09; 43(9):1680-6.
    View in: PubMed
    Score: 0.002
  113. Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? J Card Fail. 2016 Mar; 22(3):182-9.
    View in: PubMed
    Score: 0.002
  114. TGFß receptor gene variants in systemic sclerosis-related pulmonary arterial hypertension: results from a multicentre EUSTAR study of European Caucasian patients. Ann Rheum Dis. 2012 Nov; 71(11):1900-3.
    View in: PubMed
    Score: 0.002
  115. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol. 2013 Sep 10; 167(6):2710-8.
    View in: PubMed
    Score: 0.002
  116. Ventilatory efficiency and the selection of patients for heart transplantation. Circ Heart Fail. 2010 May; 3(3):378-86.
    View in: PubMed
    Score: 0.001
  117. Measurement of the myocardial performance index in ambulatory patients with heart failure: correlation with other clinical and echocardiographic parameters and independent prognostic value. Echocardiography. 2010 Feb; 27(2):123-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.